Ethical Profile
Mixed.
Not enough information to create an ethical profile.
Aspire Biopharma Holdings, Inc..
ASBP.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Aspire Biopharma Holdings, Inc. focuses on the development, manufacturing, and commercialization of pharmaceutical products. The company's activities encompass research and development, clinical trials, regulatory approvals, and the eventual marketing and sale of its pharmaceutical products. This in...Show More
Similar Companies
Value Scores
Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals-40
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100
Better Health for All
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. The articles primarily detail financial performance, regulatory actions, and FDA compliance issues, explicitly stating that information regarding living wage coverage, CEO median pay ratio, collective bargaining, safety incident rates, pay equity, worker engagement, turnover, labor violations, insecure contract share, or health insurance coverage was not available or mentioned.
1
The FDA warning letters pertain to manufacturing practices and product quality, not labor-law or human-rights violations. 2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Honest & Fair Business.
Kind to Animals
-40
Aspire Biopharma Holdings, Inc. has a key researcher, Dr. Mark J. Jaroszeski, whose foundational work in the early 1990s involved *in vivo* electroporation using animal models to deliver chemotherapeutic agents to tumors.
1
This research, which laid the groundwork for over 100 current clinical trials, 2
indicates that animal testing is an inherent part of the scientific heritage and likely ongoing R&D within the company's pharmaceutical development focus. No formal animal testing policy for Aspire Biopharma Holdings, Inc. is provided, nor is there any mention of non-animal methods being employed or prioritized by the company. 3
No War, No Weapons
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles do not contain any specific, concrete data points, metrics, or facts regarding Aspire Biopharma Holdings, Inc.'s environmental performance, policies, or initiatives. The articles discuss general environmental disclosure frameworks and regulatory initiatives but explicitly state they do not provide company-specific data for ASBP.US.
1
Respect for Cultures & Communities
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Aspire Biopharma Holdings, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points were found across the provided articles to assess Aspire Biopharma Holdings, Inc. against any of the 'Zero Waste & Sustainable Products' KPIs. The articles primarily focus on product development, clinical trials, and market launch details for new pharmaceutical products and supplements, without addressing waste management, product recyclability, packaging sustainability, or other related environmental metrics.
Own Aspire Biopharma Holdings, Inc.?
Upload your portfolio and see how all your holdings score across 11 ethical dimensions.
Audit My PortfolioAI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.